Most Recent
Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.
Gilbert +Tobin’s executive partner and corporate advisory head Tim Gordon will join Corrs Chambers Westgarth’s corporate practice based after almost 20 years at G+T.
E-commerce merchandise importer New Aim is challenging the dismissal of its trade secrets case against a former employee, who gave the contact details of the company's suppliers to a competitor after jumping ship.
The High Court has unanimously found the Federal Court has no power to allow solicitors to take a cut of a settlement or judgment in a shareholder class action against Blue Sky, saying it would be contrary to rules against contingency fees in NSW.
Mayne Pharma has denied US drug maker Cosette's claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.
A court has heard US drug maker Cosette may amend its case to accuse Adelaide's Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.
Construction PRO
A judge has allowed Charter Hall to respond to developer Pro-Invest’s expert evidence in a case claiming $100 million in damages for the lost opportunity to build a 26-storey hotel in the Sydney CBD.
Global law firm Baker McKenzie has poached a Corrs Chambers Westgarth special counsel to join the firm’s Melbourne-based employment law practice.
A defects class action against Ford, which has been on foot since 2016, might end up at the High Court for a second time, a court has heard.
The judge who tossed a class action by Quintis' shareholders should have found a restatement of assets would have materially affected the sandalwood company's share price "as a matter of common sense", a court has been told.